🟢 Scholar Rock is trading 4.83% up in pre-market

Scholar Rock is trading at $44.50, up 4.83% before the October 7, 2026 session; the reason for the move remains unclear.

• Searches found no clear new company-specific announcement to explain the move.
• The FDA approval of ISEMBYLD was announced September 11, not overnight, and does not establish a fresh catalyst.
• Broader market futures were lower; the FDA approval and clinician webinar are background, not confirmed drivers.